CX-4945: the protein kinase CK2 inhibitor and anti-cancer drug shows anti-fungal activity

CX-4945 is a selective inhibitor of protein kinase CK2 exhibiting clinical significance. Its antitumor properties arise from the abrogation of CK2-mediated pro-survival cellular pathways. The presented data reveal the influence of CX-4945 on the growth of yeast cells showing variable potency against...

Descripción completa

Detalles Bibliográficos
Autores principales: Masłyk, Maciej, Janeczko, Monika, Martyna, Aleksandra, Kubiński, Konrad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632345/
https://www.ncbi.nlm.nih.gov/pubmed/28501934
http://dx.doi.org/10.1007/s11010-017-3068-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632345/
https://www.ncbi.nlm.nih.gov/pubmed/28501934
http://dx.doi.org/10.1007/s11010-017-3068-z

Ejemplares similares